VIR,Vir Biotechnology, Inc. | Healthcare

Healthcare

VIR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Vir Biotechnology, Inc.VIR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.

It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus.

The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA.

It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus.

The company was incorporated in 2016 and is headquartered in San Francisco, California.

Latest News >

North American Construction Group Closes Strategic Acquisition of Iron Mine Contracting, a Diversified Mining Services Contractor

Apr 7, 2026

ACHESON, Alberta, April 07, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. ( NOA ) (“NACG” or the “Company”) today announced the closing of its acquisition of Iron Mine Contracting (“IMC”), with a closing date of April 7, 2026 and an economic effective date of January 1, 2026 (the “Transaction”). Total expected consideration is approximately $125 million (the “Consideration”),...

Wealthspire’s Fiducient Advisors Acquires Axia Advisory

Apr 7, 2026

$1.9 billion retirement plan consultant in Indianapolis joins growing national platform NEW YORK--(BUSINESS WIRE)-- Wealthspire, an independent wealth management, institutional advisory, and business management firm, today announced that Fiducient Advisors has completed its acquisition of Axia Advisory, an Indianapolis-based retirement plan consulting and investment advisory firm with $1.9 billion in assets under management or advisement.* The addition of Axia...

Booz Allen Completes Acquisition of Defy Security

Apr 7, 2026

Accelerating Advanced Cybersecurity for New Age of Enterprise Threats MCLEAN, Va.--(BUSINESS WIRE)-- Booz Allen Hamilton ( BAH ) today announced it has completed its acquisition of Defy Security. The transaction was previously announced on February 17, 2026. Defy provides cybersecurity technology products and services to leading financial services, healthcare, manufacturing, and retail enterprises. Combining its robust customer base, sales infrastructure,...

Caturus' Wellhead-to-Water Strategy Achieves Major Milestones in Upstream and LNG Development

Apr 7, 2026

Commonwealth LNG Project achieves full commerciality Project financing process imminent for $12.5 billion LNG project Pre-FID site objectives progressing with EPC partner Technip Energies Pending $950 million acquisition of SM Energy assets remains on track HOUSTON, April 7, 2026 /PRNewswire/ -- Caturus announced today its Commonwealth LNG project has finalized customer offtake agreements to underpin financing of its LNG facility in...